Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Good afternoon, ladies and gentlemen, and welcome to the Deutsche Börse AG Analyst and Investor Conference Call regarding the Q4 and Full Year 2024 preliminary financial results. At this time, all ...

In an apparent push for media to adopt the new White House administration’s ideals and polices, President Donald Trump has ...

Emily Fontaine, Global Head of Venture Capital, IBM; Jay Love, US Chief Investment Strategist, Mercer; and Alan McKnight, Chief Investment Officer, Regions Bank join Bloomberg Intelligence's ...